| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Laura Iop | Q43002961 |
| P2093 | author name string | G Gerosa | |
| P2860 | cites work | Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion | Q26824518 |
| Homograft replacement of the aortic valve | Q28203812 | ||
| Effect of cryopreservation on the presence of endothelial cells on human valve allografts | Q72582277 | ||
| Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients | Q73388271 | ||
| The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation | Q73413101 | ||
| Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients | Q73580561 | ||
| Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts | Q73703617 | ||
| Decellularized human valve allografts | Q73961464 | ||
| Recellularization of heart valve grafts by a process of adaptive remodeling | Q77533423 | ||
| A novel collagen hydrogel cross-linked by gamma-ray irradiation in acidic pH conditions | Q79198205 | ||
| Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience | Q81199195 | ||
| Ross Operation with decellularized pulmonary allografts: medium-term results | Q81299505 | ||
| Histopathologic findings in a novel decellularized pulmonary homograft: an autopsy study | Q81690429 | ||
| Early failure of xenogenous de-cellularised pulmonary valve conduits--a word of caution! | Q83169457 | ||
| Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep | Q83571926 | ||
| Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents | Q83573173 | ||
| Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium | Q84386900 | ||
| Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model | Q84458253 | ||
| High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect | Q84805178 | ||
| Clinical Performance of Decellularized Cryopreserved Valved Allografts Compared With Standard Allografts in the Right Ventricular Outflow Tract | Q85089604 | ||
| Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report | Q95381722 | ||
| The determination of trace amounts of protein in solutions containing surface-active substances | Q95810998 | ||
| Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates | Q28337825 | ||
| Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora | Q28361310 | ||
| Tissue engineering | Q29617288 | ||
| Structural integrity of collagen and elastin in SynerGraft® decellularized-cryopreserved human heart valves | Q31042401 | ||
| Impact of cryopreservation on extracellular matrix structures of heart valve leaflets | Q33234327 | ||
| Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity | Q33522850 | ||
| Heart valve development: endothelial cell signaling and differentiation | Q33607338 | ||
| Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes. | Q33624509 | ||
| Video-assisted and robotic mitral valve surgery: toward an endoscopic surgery | Q33713717 | ||
| Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives | Q33738436 | ||
| Solubilization of membranes by detergents | Q33911350 | ||
| Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. | Q34342654 | ||
| Tissue engineered heart valves based on human cells. | Q34579498 | ||
| Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation | Q35190282 | ||
| Hypertonic stress induces rapid and widespread protein damage in C. elegans | Q35216848 | ||
| Extracellular matrix signaling through growth factor receptors during wound healing | Q35821974 | ||
| Membrane proteins, lipids and detergents: not just a soap opera. | Q35935390 | ||
| Calcification of tissue heart valve substitutes: progress toward understanding and prevention | Q36056113 | ||
| The current state of in-vivo pre-clinical animal models for heart valve evaluation. | Q36172393 | ||
| The effect of space fillers in the cross-linking processes of bioprosthesis | Q36750414 | ||
| Prosthetic vascular grafts: wrong models, wrong questions and no healing | Q36906021 | ||
| Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts | Q37584708 | ||
| Early systemic cellular immune response in children and young adults receiving decellularized fresh allografts for pulmonary valve replacement | Q37610634 | ||
| The cryopreservation of composite tissues: Principles and recent advancement on cryopreservation of different type of tissues | Q37666669 | ||
| Tissue-engineered heart valve scaffolds. | Q37676878 | ||
| Autoimmunity and the clearance of dead cells | Q37704640 | ||
| In situ tissue regeneration through host stem cell recruitment | Q38162708 | ||
| Avoiding detrimental human immune response against Mammalian extracellular matrix implants | Q38260188 | ||
| Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody | Q38299403 | ||
| Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells | Q38299965 | ||
| The performance of ice-free cryopreserved heart valve allografts in an orthotopic pulmonary sheep model | Q38430393 | ||
| Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification | Q39113169 | ||
| Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium. | Q39634807 | ||
| Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves | Q39752016 | ||
| The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. | Q39975287 | ||
| Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results | Q40382552 | ||
| Influence of HLA matching and associated factors on aortic valve homograft function | Q40616527 | ||
| Differential transcription factor expression in human mononuclear cells in response to amphotericin B: identification with complementary DNA microarray technology | Q40780164 | ||
| Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model. | Q41200130 | ||
| Extracellular matrix in deoxycholic acid decellularized aortic heart valves | Q41864431 | ||
| A unique natural human IgG antibody with anti-alpha-galactosyl specificity | Q41878407 | ||
| Isolation of intact aortic valve scaffolds for heart‐valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features | Q42452996 | ||
| Recellularization of aortic valves in pigs | Q42479538 | ||
| First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves | Q42789753 | ||
| The Early and Midterm Function of Decellularized Aortic Valve Allografts | Q42795400 | ||
| Immunoblot detection of soluble protein antigens from sodium dodecyl sulfate- and sodium deoxycholate-treated candidate bioscaffold tissues. | Q43256092 | ||
| In vivo tissue engineering of heart valves: evolution of a novel concept | Q43740589 | ||
| Replacement of the aortic valve or root with a pulmonary autograft in children | Q44043807 | ||
| Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. | Q44069331 | ||
| Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism | Q44407752 | ||
| Regulation of the fibronectin receptor affinity by divalent cations. | Q44461951 | ||
| Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. | Q44755454 | ||
| Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging | Q44781839 | ||
| Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. | Q45972665 | ||
| Decellularized Native and Engineered Arterial Scaffolds for Transplantation | Q46045991 | ||
| Does sodium dodecyl sulfate wash out of detergent-treated bovine pericardium at cytotoxic concentrations? | Q46081125 | ||
| Genipin blues: an alternative non-toxic crosslinker for heart valves? | Q46166989 | ||
| Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. | Q46405461 | ||
| Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. | Q46543024 | ||
| Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve | Q46617797 | ||
| Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. | Q46688959 | ||
| Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection | Q46702378 | ||
| Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. | Q46944235 | ||
| Is there a possibility for a glutaraldehyde-free porcine heart valve to grow? | Q46954536 | ||
| Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). | Q47989381 | ||
| Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. | Q50969132 | ||
| Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding? | Q51096415 | ||
| Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. | Q51134100 | ||
| Clinical application of tissue engineered human heart valves using autologous progenitor cells. | Q51168556 | ||
| Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. | Q51248359 | ||
| Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. | Q51524615 | ||
| Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. | Q51524624 | ||
| Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. | Q51689037 | ||
| Decellularized native and engineered arterial scaffolds for transplantation | Q51807329 | ||
| Right ventricular outflow tract reconstruction with decellularized porcine xenografts in patients with congenital heart disease. | Q52894381 | ||
| Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing. | Q53643248 | ||
| A new sterilization technique of bovine pericardial biomaterial using microwave radiation. | Q54402433 | ||
| Solubilization of membranes by detergents | Q56851438 | ||
| Performance of the CryoValve∗ SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years | Q57916643 | ||
| Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices | Q59052137 | ||
| Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly | Q59077016 | ||
| Results of a tissue engineered pulmonary valve in humans assessed with CMR | Q59255003 | ||
| Burden of valvular heart diseases: a population-based study | Q61663367 | ||
| Mechanism of opening of the natural aortic valve in relation to the design of trileaflet prostheses | Q67237829 | ||
| Heterologous antigenicity induced in human aortic homografts during preservation | Q68115172 | ||
| Damage of porcine aortic valve tissue caused by the surfactant sodiumdodecylsulphate | Q68964647 | ||
| Heart valves: ten commandments and still counting | Q69716369 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | guided bone and tissue regeneration | Q11668581 |
| heart valve disease | Q1130519 | ||
| tissue engineering | Q1540285 | ||
| tissue scaffolds | Q72087991 | ||
| biomedical investigative technique | Q66648976 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 432901 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials | |
| P478 | volume | 2015 |
| Q48140833 | Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation |
| Q47672503 | Improvement of Decellularization Efficiency of Porcine Aorta Using Dimethyl Sulfoxide as a Penetration Enhancer. |
| Q41489828 | Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells. |
| Q41093365 | Natural Scaffolds for Regenerative Medicine: Direct Determination of Detergents Entrapped in Decellularized Heart Valves. |
| Q52563139 | Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments. |
| Q41544466 | Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve |
| Q38746402 | The Heart and Great Vessels |
| Q47112000 | The Rapidly Evolving Concept of Whole Heart Engineering |
| Q38747713 | Translational Challenges in Cardiovascular Tissue Engineering |
Search more.